Related Experiment Video
Updated: May 18, 2026

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
Published on: April 25, 2025
[Biological function explore of protein CCL15 in HCC cell lines]
1Department of Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Chemokine CCL15 promotes hepatocellular carcinoma (HCC) cell invasion and metastasis. Reducing CCL15 levels significantly decreased HCC cell migration and invasion, suggesting its role in cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Context:
- Hepatocellular carcinoma (HCC) is a prevalent cancer with high metastatic potential.
- Understanding the molecular mechanisms driving HCC metastasis is crucial for developing effective therapies.
Purpose:
- To elucidate the biological function of chemokine (C-C motif) ligand 15 (CCL15) in HCC cell lines.
- To investigate the role of CCL15 in HCC cell migration, invasion, and metastasis.
Summary:
- CCL15 expression was validated in HCC cell lines using RT-PCR and Western blot.
- Transfection with siRNA-CCL15 in high-metastasis HCCML3 cells significantly reduced cell invasion and migration.
- CCL15 overexpression was confirmed in high-metastasis HCC cell lines.
- Reduced expression of matrix metalloproteinase-9 (MMP-9) was observed in HCCML3 cells transfected with siRNA-CCL15.
Impact:
- CCL15 plays a significant role in promoting HCC cell invasion and metastasis.
- CCL15 may facilitate HCC progression through MMP-9 regulation and by enhancing invasion potential.
- Targeting CCL15 could be a potential therapeutic strategy for inhibiting HCC metastasis.
More Related Videos
07:25Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery
Published on: August 18, 2023
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021